Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy of a Modular App-Based Pelvic Floor Muscle Training Program for Postoperative Continence Recovery After Radical Prostatectomy: A Multi-Center Randomized Controlled Trial (PELVINTENSE Study).

Cancers·2026
Same author

Acute Skeletal Muscle Activation Through Physical Exercise and Its Effects on Cognitive Performance and Neurobiological Markers in Adults: A Scoping Review.

Muscles (Basel, Switzerland)·2026
Same author

Artificial Intelligence-Assisted Error Detection in Complex Clinical Documentation: Leveraging Large Language Models to Enhance Patient Safety in Oncology.

JCO clinical cancer informatics·2026
Same author

Direct-to-Consumer Teledermatology for Male Androgenetic Alopecia: Narrative Review.

JMIR dermatology·2025
Same author

Enabling Just-in-Time Clinical Oncology Analysis With Large Language Models: Feasibility and Validation Study Using Unstructured Synthetic Data.

JMIR medical informatics·2025
Same author

Metabolic phenotype and gender may predict treatment outcomes of atezolizumab in extensive-stage small cell lung cancer.

Translational lung cancer research·2025
Same journal

How Does That Large Language Model Make You Feel?

Journal of medical Internet research·2026
Same journal

Transformation Versus Innovation in Digital Health Care and the Future of Clinical AI.

Journal of medical Internet research·2026
Same journal

Building a Malaria Intelligence System for Real-Time Prediction and Data-Driven Intervention Planning.

Journal of medical Internet research·2026
Same journal

Therapeutic Interaction Features of AI Chatbots in Depression Interventions: Systematic Review and Meta-Analysis.

Journal of medical Internet research·2026
Same journal

Large Language Model Versus Multidisciplinary Team: Feasibility Study of Pancreatic Cancer Management Recommendations.

Journal of medical Internet research·2026
Same journal

Centers for Medicare & Medicaid Services to Launch Landmark ACCESS Program.

Journal of medical Internet research·2026
See all related articles

Related Experiment Video

Updated: May 27, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Sequencing AI Automation and Data Interoperability in Oncology Using a Scenario-Planning Framework Coupled With

Peter May1, Sabine D Brookman-May2, Edward Garrahy3

  • 1Department of Medicine III, School of Medicine and Health, Technical University of Munich, Ismaninger Str. 22, Munich, Bavaria, 81675, Germany, 49 89-4400 ext 8753.

Journal of Medical Internet Research
|May 25, 2026
PubMed
Summary
This summary is machine-generated.

Integrating artificial intelligence (AI) into oncology care can improve patient throughput and reduce treatment times. However, successful AI adoption requires robust data infrastructure to avoid bottlenecks and ensure system resilience.

Keywords:
AIartificial intelligencedata interoperabilitydiscrete-event simulationmedical futures studiesscenario planning

More Related Videos

Radiation Planning Assistant - A Web-based Tool to Support High-quality Radiotherapy in Clinics with Limited Resources
05:18

Radiation Planning Assistant - A Web-based Tool to Support High-quality Radiotherapy in Clinics with Limited Resources

Published on: October 6, 2023

Related Experiment Videos

Last Updated: May 27, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Radiation Planning Assistant - A Web-based Tool to Support High-quality Radiotherapy in Clinics with Limited Resources
05:18

Radiation Planning Assistant - A Web-based Tool to Support High-quality Radiotherapy in Clinics with Limited Resources

Published on: October 6, 2023

Area of Science:

  • Health systems research
  • Artificial intelligence in healthcare
  • Operational modeling

Background:

  • Health systems face uncertainty integrating autonomous artificial intelligence (AI) agents into oncology workflows.
  • Traditional forecasting methods are inadequate for predicting AI's second-order operational impacts, such as governance saturation and bottleneck migration.
  • System-level dynamics influenced by AI integration affect diagnosis, treatment, and health system resilience.

Purpose of the Study:

  • To develop a proof-of-concept framework for evaluating oncology AI adoption strategies.
  • To couple qualitative scenario planning with quantitative discrete-event simulation for stress-testing AI integration.

Main Methods:

  • Defined a strategic state space using AI automation intensity and data interoperability, creating four distinct future scenarios.
  • Translated qualitative scenarios into a discrete-event simulation model with a 3-year operational horizon.
  • Quantified system performance metrics including referral-to-treatment interval (RTTI), throughput, volatility, and resource constraints.

Main Results:

  • The fully integrated AI scenario maximized capacity and halved the mean RTTI, comparable to major pathway redesigns.
  • Isolated AI adoption without data infrastructure reduced performance, increasing RTTI by 26% and decreasing throughput due to governance saturation.
  • Identified bottleneck migration and demonstrated that prioritizing data interoperability reduced transition volatility compared to an automation-first approach.

Conclusions:

  • Integrating qualitative scenario planning with quantitative simulations provides a systematic method for evaluating oncology AI adoption.
  • The framework offers a replicable approach for health leaders to model digital transformation scenarios amidst uncertainty.
  • Future work should incorporate financial and health equity dimensions, establishing simulation-based scenario planning as a key tool in medical futures studies.